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ABSTRACT 
Family Doctors are in an ideal situation to counsel patients on most medical technologies and 
new developments. In this sense they are in the best position to guide and counsel patients on 
genetic testing and screening. Indeed most often it is the patient who seeks counsel from the Family 
Doctor (General Practitioner). The special nature of genetic tests and the potential to exploit people's 
money with dubious testing puts the doctor in a special situation. Whilst it is argued that the Family 
Doctor maintains a strategic position to impart information to the patient, it is also argued that the 
new nature of genetic tests and the way the family may be affected, (including the multitude of 
ethical dilemmas these tests may pose), favours the position that Family Doctors should be the 
health professionals who should impart generic genetic counselling. Specialised genetic counsel-
lors may then continue to dedicate their time to special cases. Tests should not be made available 
over-the-counter. It is the onus of the Family Doctor to refer patients for further counse ling should 
this be necessary. Colleges and Academies of Family Physicians are in the ideal place to outpace 
industry especially in second and third world countries. 
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INTRODOCTION 
Genetic information has a tremendous potential 
to harm as well as to help and stands to affect a 
broad number of family members (McCanse, 2001). 
Even well educated patients may be ill- prepared to 
understand or deal realistically with the results of 
genetic tests . The primary care culture is different 
from the genetics culture but primary care doctors 
are more patient-oriented asking what specific as-
pects of a genetic approach to this health problem 
(or potential problem) are likely to benefit this 
patient. Howard Brody warned family doctors about 
the perils of genetic testing and the role the family 
physician must play (Ibid., p.l) . The ability to 
genetically screen for diseases far outpaces the 
ability to treat conditions, such as breast cancer, 
Alzheimer's disease and prostate canceT. Nonethe-
less people often consider genetic tests as some 
sort of cure or prevention of the condition (Lapp, 
2002). 
At the same time Chandros Hull and Prassas 
(200l) have shown how companies may use ad-
vertising to their advantage to entice people into 
believing that they should have genetic tests. They 
sometimes advise potential patients that there is no 
need to consult the family doctor or anybody else 
as their own 'experts' will guide the patients into 
what tests they should carry out. However genetic 
tests may not only affect the individual adversely, 
but also family members of that person carrying out 
the tests. In this context it is fair for family physi-
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cians and their societies and colleges to be wary of 
the effect these tests can have on family members. 
Conversely family doctors, without the proper Con-
tinuing Medical Education (CME) imparted specifi-
cally to meet the needs of ongoing ethical dilem-
mas in genetic tests, may find themselves ordering 
such tests too liberally, once it is the patient who 
request them, believing they are respecting the 
individual's autonomy. 
Weber and Corban (1996) note that although 
today geneticists perform most testing and 
counseling for genetic disorders, in the near future 
family physicians will increasingly become respon-
sible for this role. Whilst the reasons for testing may 
be simple, they are likely to ignite fierce issues 
regarding cost, ethics, insurability, patient expec-
tations and information which family members may 
wish not to know. How should family doctors con-
sider their role with regard to genetic testing and 
counseling? 
What are the concerns of genetic tests? 
Why should genetic tests cause concern to fam-
ily doctors more than any other form of test? The 
prime reason is indeed the novelty of these tests 
and the aura they are raising. Awareness cam-
paigns sponsored by companies need to be consid-
ered for what they may actually be - an impetus for 
them to promote their product. While such cam-
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paigning need not be bad in itself, if it is to be 
endorsed by the medical profession , the latter has 
the responsibility towards society not to be an 
accomplice in enticing patients to spend more than 
they should on such tests. Definitely not e verybody 
need do genetic tests and therefore fears must be 
quelled . Who is in a better position to quell such 
fe a rs than fa mily p h ys icians who enjoy th e trust of 
patients a nd their families? 
Consider the testing for the breast cancer genes 
BRCA 1 & 2 . Those who test positive for the 
mutations of these genes via a commercially avail-
able genetic test are at an increased risk of having 
breast cancer compared to the general population . 
Some may argue therefore that once these tests are 
available it is not the onus of any physician to try to 
convince someone not to do them. Yet people may 
not be aware of the implications the result of such 
a test may have on employment and insurability . 
Furthermore , it is uncertain whether they know 
what , if anything , can be done with such knowledge 
and how this will affect their mental well being and 
that of their family. In the event such a test is 
positive, it does not necessarily imply that the 
person will have cancer; yet it puts them into a high 
risk category justifying insurers to charge a higher 
premium or not to insure them at all for breast 
cancer. This has enticed many States in the USA to 
introduce laws protecting against inappropriate 
access of such tests to the public. In other countries 
such laws do not yet exist. 
Recent studies on bilateral prophylactic 
oophorectomy vs. radical mastectomy (Kauff, 2002; 
Rebbeck, 2002) show that this is a highly evolving 
field in which it is wise to seek the advice of a 
doctor. Haber (2002), analysing the relevance in 
the statistics of such results , shows only that more 
studies a re necess a ry . Thus b y no means is there 
a ny ce rta inty about outcomes of BRCA testing 
other tha n to recommend it to women past child-
bearing a g e and counseling the m on oophore c -
tomy s hould they test positive . Aga in this opera tion 
does not protect them completely from breas t can-
c er, e s pe cially when th e re a re a s yet no s tudies to 
show whether the require d Hormon e Re pla cement 
Therapy (to preve nt prem a ture side effects of the 
artificially -induced m enopa use; namely increased 
cardiovascular risk and osteoporosis) may itself 
contribute to an increased incidence of breast can-
cer which the oophorectomy is being performed to 
eliminate. Even though the effectiveness of bilat -
eral prophylactic radical mastectomy was demon-
strated recently (Meijers, 2001), the controversy 
over such radical treatment remains. 
Role of the Family Physician 
Whereas it is undisputed that the Genera l Prac-
titioner is in an ide al position to counsel p a tients on 
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genetic testing (BMA, 1998, p. 120; Starfield et aI., 
2002) and to know when to refer patients for 
specialized counselling, Brody argues that a bal-
ance has to be struck between the physicians' 
hunches, the patient's wishes and the evidence of 
clinical trials (Lapp, 2002) . One concern which is 
not being addressed adequately, for e xample, is the 
implic ations suc h tests pose fo r family mem bers. A 
possible solution he proposes is that the family 
doctor is in a position to set up a 'family covenant' 
before an individual goes through with testing . 
Such a document would be negotiated among the 
family members with the help of the physician. 
Family members who 'opt in ' set conditions are 
privy to the knowledge that comes out (Lapp, 
2002). Yet the concept of covenant is lagging 
behind advances in genetic testing and it is doubtful 
how much such a covenant is possible before 
family doctors establish themselves as the agents 
of basic genetic counselling. 
The BMA document argues that primary care 
physicians should be able to identify patients and 
families who would need further genetic counsel-
ling by specialists, arguing that the rapidity with 
which genetic technology is developing and the 
complexity of the decisions to be made in relation 
to genetic testing mean that specialized genetic 
counselling , both pre-test and post-test, is likely to 
be required (BMA, 1998, p . 121). This however 
only refers to identification of individuals and fami-
lies who need specialist counselling. It is unlikely 
that genetic counsellors can reach the public as 
easily as family physicians because of their smaller 
numbers and their inferior accessibility, especially 
considering the increasing number of generic ge-
netic tests being advertised. Moreover the family 
doctor already knows much about the family and its 
requirements and would be able to identify who 
would benefit from genetic information . He/she is 
famil iar with the background and family dynamics 
in a way that a specialized counsellor can never be: 
it is information obtained over time within the 
context of practicing family medicine. Indeed if it 
were possible fo r the couns ellor to arrive at s uch 
knowledge , it could be a rgued that th is would be a 
repetit ion and waste of time for hea lth profession -
als a nd patie nts alike. 
Boxes 1 and 2 (Ibid., p. 123-124) show the 
process of genetic counselling and the framework 
for exploring decisions, laid down by both the BMA 
and the American Society for Human Genetics. 
Nothing in this list is in fact beyond the capabilities 
of the average primary care physician or family 
doctor. When patients seek the advice of the family 
p hysician, it is appropriate that the latter should be 
able to handle most g e neric questions and counsel-
ling, referring on to the s pecialist only those who 
have serious genetic inheritance problems. For 
those patients seeking to know more a bout cance r 
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genes, paternity testing and even genetic screening 
of the unborn, the family physician is in an ideal and 
maybe better position to impart advice. Family 
physicians are moreover prescriptive by nature and 
thus tend to be more directive than the average 
non-directive genetic counsellor (BMA, 1998, p. 
122). 
There are additional reasons why generic ge-
netic counselling should be imparted by family 
doctors. The strategically placed position of the 
family physician favours the role that genetic coun-
selling should play in primary care. It is the respon-
sibility of family physicians as a group to take on 
the role of protecting families against commercial 
interest. This is particularly important because 
people may not be aware of the implications to 
other members of the family when doing a genetic 
test. Who else but the family physician is in the 
central stage to counsel directly family members? 
This is all more important because to await the 
development of genetic services and to wait for 
specialized counsellors to deal with the true impact 
of genetic testing is unrealistic even in the United 
Kingdom and the United States, let alone the rest of 
the world. 
Of course the family doctor can never replace 
the role of the specialized genetic counsellor just as 
he can never replace the specialized radiographer 
or cardiologist. But the energy of the specialist 
counsellor is better spent on hard core cases like 
Huntington's chorea and Tay Sachs disease, rather 
than where the industry is striking hard, namely the 
cancer genes and such tests as 'cardiovascular 
panels' and 'thrombosis panels'. The latter are 
targeted to raise public awareness in order to sat-
isfy a profit motive rather than a genuine social 
need. 
Consider a country like Malta where recently a 
newl:;' formed company started to offer genetic 
testing to the public . Presently it uses the services 
of specialists and family doctors for referrals. No 
form of counselling is offered to the patient, leaving 
this onus on the doctor. Indeed there has been little 
to promote awareness among the medical profes-
sion of the special nature of genetic tests and the 
implications they may have on the life ofthe person 
seeking those tests, and on his/her family. This 
fertile ground is the ideal incubator for releasing 
'awareness information' onto the public catching 
doctors off guard. Before there is enough time to 
prepare for genetic counselling services, people 
will start believing, as happens in other countries, 
that there is some inherent cure in carrying out 
such tests (Lapp, 2002) . Doctors, on the other 
hand, unaware of the implications of such tests, as 
has been the BMA's subtle warning will not counsel 
the public properly . Specialized services, even if 
they do exist in the main general hospital , are not 
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enough to handle the everyday questions regarding 
genetic tests and definitely cannot inform patients 
adequately about what tests are really necessary. 
Appointments with the service may well run into 
months , and then just to handle the cases that truly 
need specialized counselling. 
Family doctors are strategically placed to train 
themselves in imparting this counselling, this being 
a core medical subject already in their realm. [t is 
the responsibility of colleges, associations and acad-
emies of family physicians to stimulate members to 
learn more about genetic counselling. 
The coming of age of Family Practice 
Another important perspective is the coming of 
age of family practice. Whilst the history of medi-
cine shows that the family doctor or community 
doctor was the traditional doctor (Porter, 1996, p. 
118), the last century saw a surge of specialties and 
sub-specialities. [n Britain the Royal College of 
General Practitioners was founded after the war and 
incorporated almost all general practitioners. [t 
became the strongest political body in Britain to 
bargain with government over the structure of the 
National Health Service. [n the United States, the 
American Academy of Family Physicians brought 
together Family Doctors raising the status of Fam-
ily Medicine to that of a speciality . Similar roads 
were taken later in other countries. 
Family doctors now provide more and more 
services, which services that can be offered to 
people at more reasonable rates making it more 
acceptable to insurance companies. GPs have al-
ways traditionally carried out minor surgery such 
as removal of sebaceous cysts, cautery of warts 
and injection of internal haemorrhoids . Nowadays 
more and more GPs take on more engaging non-
invasive surgery such as removal of lipomas, injec-
tion of varicose veins, circumcision and even 
haemorroidectomies (Brown , 1992) . Studies have 
shown (Siepel, 2000) that family doctors who at-
tend a course in ultrasonography can perform 
ultrasounds as part of the physical examination, 
detecting pathology such as renal tumours, aortic 
aneurysms and others, before any signs and symp-
toms are noticed by doctor and patient respec-
tively. Family doctors in the United States train to 
perform sigmoidoscopy, gastroscopy, colposcopy 
and can even have a whole radiological set-up if 
economically viable. All of this in the interest of 
quick diagnostics bypassing long referral lists and 
delays in a secondary care setting. [n this setting it 
is reasonable to assume that the family doctor , with 
continued medical education (CME) is taking onto 
himself more and more diagnostic techniques which 
not only increase the scope of general practice but 
which result in more benefit to patients. With proper 
CME a genetic counselling service to people and 
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their families is within the scope and definition of 
family practice. 
What is needed with the impact of genetic tech-
nologies therefore is a primary care setting that can 
explain tests to all people, not only to those who 
have some genetic disorder in their lineage. It is 
reasonable to assume that any woman may request 
information about whether she should have a BRCA 
test done . She may not know that she needs coun-
selling (in terms of implications for herself and her 
relatives, for insurance purposes, etc). Family phy-
sicians can bring a broader scope to genetic coun-
selling. They are trained to think of issues such as 
getting patients to get their house in order vis-a-vis 
insurance before getting tests done (Lavallee, 1999). 
Conversely it is unreasonable to assume or 
request genetic counsellors to have to deal with this 
sort of mass population counselling. They would 
lose time that is valuable for what they are doing at 
present - counselling to those families, which may 
indeed be identified by family doctors, who require 
further in-depth evaluation. Unless genetic coun-
sellors increase in numbers and become almost as 
common as family doctors they may not be able to 
handle the demand for information which neces-
sarily would need to be imparted to keep up with the 
media and the rapidly expanding genetic industry. 
Starfield et al. (2002, p. 51) argue that when one 
considers genetic problems, in initiation of diagno-
sis and even management, primary-care-centred 
systems offer the greatest potential for improving 
health. 
The responsibility of Associations and Colleges 
Family physician Nancy Stevens stresses the 
importance of injecting the family practice per-
spective into genetic medicine (McCanse, 2000). 
As this perspective is still underrepresented in 
conversations of genetic medicine, it follows that 
patients of family practitioners are 
underrepresented. For example, she points out that 
only one from a high-risk family tends to benefit 
from BRCA testing. Once it is accepted that the 
family doctor has this role to play in imparting 
knowledge and genetic counselling to patients, 
associations and colleges have an obligatory role 
to see that its members get the CME in genetic 
counselling that is required. Family doctors, by 
their very nature, are already in a position to give 
evidence-based information, genetics being one 
specialty they have always had in their curriculum. 
It would be unreasonable not to accept their role in 
providing such evidence-based counselling. 
Associations and colleges of family doctors, 
which strive to guarantee excellence, have a spe-
cial role to play here. But primary-care-centred 
systems may pose a risk of under-detection and 
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under-management of genetic problems if infor-
mation and other educational networks do not 
actively support practitioners (Starfield et al. 2002, 
p. 51). Whereas it may be obvious that a family 
doctor intending to carry out diagnostic ultrasonog-
raphy would require training, it may not be that 
obvious that to provide genetic counselling one 
also needs training, because genetics has always 
formed part of the medical undergraduate curricu-
lum. The focus of counselling is not on Mendelian 
inheritance explained in layman terms, but is a 
matter of explaining the social, legal and ethical 
implications of these tests and also of having a 
clear understanding of why they are so different 
from simply having a blood count. Doctors need to 
understand and explain that genetic tests are largely 
non-therapeutic and predictive. The patient there-
fore needs to be empowered with information by 
someone who understands the full potential of 
these tests and how industry may exploit fear of 
disease without concern for implications on em-
ployment and insurability and impact on other 
family members. 
Associations must guarantee that their mem-
bers will explain the harm/benefit of genetic testing 
and screening. They must also guarantee that they 
will continue to seek the interests of the family and 
not only of individual people seeking testing. In 
other words family doctors need to maintain the 
trust of the public, demonstrating that financial 
gain is not the main motive of for the counselling as 
may be the case for the company providing that 
test. 
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